PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

被引：1385

作者：

Maeda, N ^{[1
]}

Takahashi, M ^{[1
]}

Funahashi, T ^{[1
]}

Kihara, S ^{[1
]}

Nishizawa, H ^{[1
]}

Kishida, K ^{[1
]}

Nagaretani, H ^{[1
]}

Matsuda, M ^{[1
]}

Komuro, R ^{[1
]}

Ouchi, N ^{[1
]}

Kuriyama, H ^{[1
]}

Hotta, K ^{[1
]}

Nakamura, T ^{[1
]}

Shimomura, I ^{[1
]}

Matsuzawa, Y ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci B5, Suita, Osaka 5650871, Japan

来源：

DIABETES | 2001年 / 50卷 / 09期

关键词：

D O I：

10.2337/diabetes.50.9.2094

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulin resistance and its dreaded consequence, type 2 diabetes, are major causes of atherosclerosis. Adiponectin is an adipose-specific plasma protein that possesses anti-atherogenic properties, such as the suppression of adhesion molecule expression in vascular endothelial cells and cytokine production from macrophages. Plasma adiponectin concentrations are decreased in obese and type 2 diabetic subjects with insulin resistance. A regimen that normalizes or increases the plasma adiponectin might prevent atherosclerosis in patients with insulin resistance. In this study, we demonstrate the inducing effects of thiazolidinediones (TZDs), which are synthetic PPAR gamma ligands, on the expression and secretion of adiponectin in humans and rodents in vivo and in vitro. The administration of TZDs significantly increased the plasma adiponectin concentrations in insulin resistant humans and rodents without affecting their body weight. Adiponectin mRNA expression was normalized or increased by TZDs in the adipose tissues of obese mice. In cultured 3T3-L1 adipocytes, TZD derivatives enhanced the mRNA expression and secretion of adiponectin in a dose- and time-dependent manner. Furthermore, these effects were mediated through the activation of the promoter by the TZDs. On the other hand, TNF-a, which is produced more in an insulin-resistant condition, dose-dependently reduced the expression of adiponectin in adipocytes by suppressing its promoter activity. TZDs restored this inhibitory effect by TNF-alpha. TZDs might prevent atherosclerotic vascular disease in insulin-resistant patients by inducing the production of adiponectin through direct effect on its promoter and antagonizing the effect of TNF-alpha on the adiponectin promoter.

引用

页码：2094 / 2099

页数：6

共 43 条

[1] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].